Exelixis
EXEL
#1826
Rank
A$16.50 B
Marketcap
A$61.57
Share price
-1.20%
Change (1 day)
12.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company